Amanda Blanchet’s Post

We have been thinking about the challenges faced by regulators setting prices for passive access remedies. Firstly, the regulator needs to determine which passive remedy or remedies are appropriate and proportionate for the specific market conditions, including what type of competition it is trying to encourage; then it has to establish the appropriate cost base; and finally, determine how to structure the pricing and the recovery of the relevant costs between the regulated provider and access seekers. All of these stages involve judgement calls, as a number of different options exist and several may present as suitable for the specific market conditions. As we have worked across several markets tackling these challenges, we have tried to summarise the high level issues in this paper. We would love to hear your thoughts.

Updates to CMS regulations could make calculating the prior-year intern-to-bed ratio more complex. FORVIS’ GME professionals offer insight in this article.

Updates to CMS regulations could make calculating the prior-year intern-to-bed ratio more complex. FORVIS’ GME professionals offer insight in this article.

Central and State Governments are taking leading steps for proliferation of the Renewable Energy Sector in the country by way of notifying/amending key policy and regulatory interventions. Here are the details of the RE Policy and Regulatory updates for the month of December 2023. Jeevan Kumar Jethani

Earlier this year KFF found that nearly half of voters say that lowering out-of-pocket costs is the top health care priority to address. #IRA's $2,000 Part D OOP cap will help begin to fix this, but CMS's proposal for the next round of government negotiated price-setting will neither improve patient access nor help ensure more & better medicines will be developed. We submitted formal comments on the proposed regulations. If the government is going to impose price controls on drugs, it needs to ensure that patients -- not health plans, #PBMs, nor health systems -- see those savings. Here's how @CMSGov can improve IRA's rules: 1. Ensure that price-set drugs are put on Part D & MAPD plans lowest OOP cost formulary tiers. 2. Don’t let health systems eat up Rx savings through markups. 3. Reject use of outdated cost-effectiveness analysis (CEA) calculations to set drug prices or limit beneficiary access. Read our full letter here: https://lnkd.in/ea2csQhr

NCQA invites the public to comment on proposed changes to the HEDIS® (Healthcare Effectiveness Data and Information Set) measure set. Items available for public comment include proposed new measures and changes to existing measures.     This is an opportunity for health plans, purchasers, consumers, and other stakeholders to weigh in on the relevance, scientific soundness, and feasibility of new and revised measures for HEDIS.     Learn more about the proposed changes and how to submit comments by March 13.  https://lnkd.in/g2yZYu2j

Navigating state and federal turnaround time (TAT) requirements is crucial for compliance and efficiency. Our latest insight paper outlines best practices to streamline your processes and meet regulatory standards effectively. Optimize your organization's TAT management today: https://lnkd.in/gyhPxy6x #TATCompliance #RegulatoryStandards #BestPractices #BHMHealthcareSolutions

⏰ The end of the transition period for existing national poison centre notification according to Art. 45 of CLP is approaching. ⚠️ Remember, there's no automatic data migration from national systems to the harmonised format according to Annex VIII of CLP regulation. 📋 Get ready to ensure compliance with Poison Centre Notification (PCN) by 01 January 2025! 📅 Learn more: https://lnkd.in/dCKV9PW7

https://lnkd.in/eibHkui3 Anybody that works in the sector has known this for years. It will be interesting to see what happens next but when the regulator requires improvement, you know that things are in a mess.

Are you facing looming regulatory deadlines? You are not alone. New research from CSC reveals a third of private market professionals admit to leaving the implementation of regulatory changes until the last minute. Learn more here: https://lnkd.in/emjC_EJa. #privatemarkets #SPV #dealmaking